Primary Objective(s) To collect clinical data related to the treatment outcomes of Pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical intervention. Secondary Objective(s) To collect data on adverse events and complications related to IRE treatment. The AHPBA (Americas Hepato-Pancreato-Biliary Association) will be responsible for data collection and will periodically audit the data for quality assurance purposes. The AHPBA will review outcomes reported by each participating Research Institution and if outcomes are in the lower percentile, the investigators will be offered support to analyze the reasons for the suboptimal outcomes and may seek support to improve outcomes. The participating Research Institutions will receive a certificate annually that acknowledges their participation in the Research Project.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical data collected prospectively and post-operatively at different timepoints
Timeframe: pre-operatively and several timepoints post-operatively until 4 years
CBC blood test
Timeframe: pre-operatively and several timepoints post-operatively until 4 years
Chemistry blood test
Timeframe: up to 4 years following operation
CA19-9
Timeframe: pre-operatively and several timepoints post-operatively until 4 years
Physical exam-Height
Timeframe: pre-operatively and several timepoints post-operatively until 4 years
Physical exam- Weight
Timeframe: pre-operatively and several timepoints post-operatively until 4 years
CT scan of the tumor area-diameter
Timeframe: pre-operatively and several timepoints post-operatively until 4 years
CT scan of the tumor area- vessel narrowing
Timeframe: pre-operatively and several timepoints post-operatively until 4 years
CT scan finding new lymph nodes
Timeframe: pre-operatively and several timepoints post-operatively until 4 years